logo

Janet McGill, MD

Janet McGill, MD

Endocrinology Saint Louis, MO

Associate Professor of Medicine, Washington University St Louis

Office Address

Office Map
  • 4570 Childrens Pl
    Center for Advanced Disease
    Saint Louis, MO 63110
    Phone: (314) 362-3500
    Fax: (314) 362-4833

Dr. McGill's Clinical Specialties & Interests

  • Endocrinology: General Endocrinology

Dr. McGill's Education & Medical Training

  • Washington University/Barnes-Jewish HospitalWashington University/Barnes-Jewish HospitalFellowship, Endocrinology, Diabetes and Metabolism
  • William Beaumont HospitalWilliam Beaumont HospitalFellowship, Endocrinology, Diabetes and Metabolism
  • William Beaumont HospitalWilliam Beaumont HospitalResidency, Internal Medicine
  • MI State Univ, Coll of Human MedMichigan State University College of Human MedicineMedical School

Dr. McGill's Certifications & Licensure

  • MO State Medical LicenseMO State Medical LicenseActive through 2013
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineEndocrinology & Metabolism

Dr. McGill's Awards, Honors, & Recognition

  • American Association of Clinical EndocrinologyFellow (FACE)American Association of Clinical Endocrinology

Dr. McGill's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Diabetes Research And Training Center
    Diabetes Research And Training CenterNational Institute Of Diabetes And Digestive And Kidney Diseases
    2007 - 2007
  • Bypass Angioplasty Revascularization Investigation 2 Diabetes (Bari 2d)
    Bypass Angioplasty Revascularization Investigation 2 Diabetes (Bari 2d)National Center For Research Resources
    2005 - 2005
  • Bypass Angioplasty Revascularization Investigation 2 Diabetes (Bari 2d).
    Bypass Angioplasty Revascularization Investigation 2 Diabetes (Bari 2d).National Center For Research Resources
    2004 - 2004
  • The Dream Study
    The Dream StudyNational Center For Research Resources
    2004 - 2007
  • Early Diabetes Intervention Program. (EDIP)
    Early Diabetes Intervention Program. (EDIP)National Center For Research Resources
    2004 - 2004
  • Correlation Of 15ag To Established Glycemia Markers In Diabetes
    Correlation Of 15ag To Established Glycemia Markers In DiabetesNational Center For Research Resources
    2004 - 2004
  • Inhaled Human Insulin Therapy In Type 2 Diabetes
    Inhaled Human Insulin Therapy In Type 2 DiabetesNational Center For Research Resources
    2000 - 2002
  • External Continuous Subcutaneous Insulin Aspart Infusion In NIDDM
    External Continuous Subcutaneous Insulin Aspart Infusion In NIDDMNational Center For Research Resources
    2000 - 2002
  • Comparison Of Tcpi Td-Glucose With Finger Stick Methods
    Comparison Of Tcpi Td-Glucose With Finger Stick MethodsNational Center For Research Resources
    2000 - 2002
  • Plant Sterols In Cholesterol Absorption
    Plant Sterols In Cholesterol AbsorptionNational Center For Research Resources
    2000 - 2002
  • Diabetes Center--Clinical Research Facility, Research, And Training
    Diabetes Center--Clinical Research Facility, Research, And TrainingNational Center For Research Resources
    2000 - 2002
  • Nabumetone, Celcoxib &Ibuprofen On Blood Pressure Control In Hypertension
    Nabumetone, Celcoxib &Ibuprofen On Blood Pressure Control In HypertensionNational Center For Research Resources
    2000 - 2002
  • Effect Of A-100 On Glycemic Control In Overweight NIDDM Treated With Metformin
    Effect Of A-100 On Glycemic Control In Overweight NIDDM Treated With MetforminNational Center For Research Resources
    2000 - 2002
  • Inhaled Vs. Subcutaneous Human Insulin Therapy In Type 2 Diabetes
    Inhaled Vs. Subcutaneous Human Insulin Therapy In Type 2 DiabetesNational Center For Research Resources
    2000 - 2002
  • Evaluate 3 Fixed Doses Of SDZ Djn 608 In NIDDM
    Evaluate 3 Fixed Doses Of SDZ Djn 608 In NIDDMNational Center For Research Resources
    2000 - 2002
  • Gi262570 Sodium Tablets W/ Metformin For 26 WKS In NIDDM
    Gi262570 Sodium Tablets W/ Metformin For 26 WKS In NIDDMNational Center For Research Resources
    2000 - 2002
  • Gi262570 Sodium Tablets Monotherapy For 26wks In NIDDM
    Gi262570 Sodium Tablets Monotherapy For 26wks In NIDDMNational Center For Research Resources
    2000 - 2002
  • Evaluation Of Multi Dose Regimen L-753,037 In African Americans With Hypertension
    Evaluation Of Multi Dose Regimen L-753,037 In African Americans With HypertensionNational Center For Research Resources
    2000 - 2002
  • External Continuous Infusion Of Insulin Aspart, Lispro &Buffered Regular In IDDM
    External Continuous Infusion Of Insulin Aspart, Lispro &Buffered Regular In IDDMNational Center For Research Resources
    2000 - 2002
  • SDZ Djn 608 Monotherapy Compared To Glibenclamide Monotherapy B304 E
    SDZ Djn 608 Monotherapy Compared To Glibenclamide Monotherapy B304 ENational Center For Research Resources
    1999 - 2002
  • Early Diabetes Intervention Program (EDIP)
    Early Diabetes Intervention Program (EDIP)National Center For Research Resources
    1999 - 2005
  • Metformin And Glyburide Combination Products In Diabetes Patients
    Metformin And Glyburide Combination Products In Diabetes PatientsNational Center For Research Resources
    1999 - 2002
  • Oral Gi262570x Monotherapy 12weeks Duration Subjects With Type2 Diabetes
    Oral Gi262570x Monotherapy 12weeks Duration Subjects With Type2 DiabetesNational Center For Research Resources
    1999 - 2002
  • Repaglinide And Troglitazone In Treatment Of Type II Diabetes Mellitus
    Repaglinide And Troglitazone In Treatment Of Type II Diabetes MellitusNational Center For Research Resources
    1999 - 2002
  • Brl49653c Combination With Glyburide To Patients With Diabetes
    Brl49653c Combination With Glyburide To Patients With DiabetesNational Center For Research Resources
    1999 - 2002
  • Brl49653 Combination With Insulin To Patients With Noninsulin Dependent Diabetes
    Brl49653 Combination With Insulin To Patients With Noninsulin Dependent DiabetesNational Center For Research Resources
    1999 - 2002
  • Oral Gi26257ox In Patients W Type II Diabetes Mellitus
    Oral Gi26257ox In Patients W Type II Diabetes MellitusNational Center For Research Resources
    1999 - 1999
  • Antiproteinuric Effects Of Omapatrilat And Amlodipine In Type II Diabetes
    Antiproteinuric Effects Of Omapatrilat And Amlodipine In Type II DiabetesNational Center For Research Resources
    1999 - 2002
  • 52 Week, Orlistat Treatment In Obese Patients With Type 2 Diabetes Mellitus
    52 Week, Orlistat Treatment In Obese Patients With Type 2 Diabetes MellitusNational Center For Research Resources
    1999 - 2002
  • 28 Week OPEN Clinical Trial Comparing HOE 901 Insulin With NPH Human Insulin
    28 Week OPEN Clinical Trial Comparing HOE 901 Insulin With NPH Human InsulinNational Center For Research Resources
    1998 - 1999
  • 16 Week Multicenter Clinical Trial Comparing H0e901 W/ NPH Human Insulin
    16 Week Multicenter Clinical Trial Comparing H0e901 W/ NPH Human InsulinNational Center For Research Resources
    1998 - 1999
  • Oral Zopolrestat In Subjects With Peripheral Symmetrical Diabetic Polyneuropathy
    Oral Zopolrestat In Subjects With Peripheral Symmetrical Diabetic PolyneuropathyNational Center For Research Resources
    1998 - 2002
  • Randomized Study To Determine Effects Of Subcutaneous Recombinant Leptin
    Randomized Study To Determine Effects Of Subcutaneous Recombinant LeptinNational Center For Research Resources
    1998 - 1999
  • BRL 49653c Admin 1X Day To PTS W/ NIDDM Inadequately Controlled On Glyburide
    BRL 49653c Admin 1X Day To PTS W/ NIDDM Inadequately Controlled On GlyburideNational Center For Research Resources
    1998 - 1999
  • 26 Weeks Of BRL 49653c Given 2X Day To Patients W/ NIDDM &Inadequate Control
    26 Weeks Of BRL 49653c Given 2X Day To Patients W/ NIDDM &Inadequate ControlNational Center For Research Resources
    1998 - 2002
  • Effects Of Subcutaneous Admin Of Insulin &Rhigf 1 In Subjects With IDDM
    Effects Of Subcutaneous Admin Of Insulin &Rhigf 1 In Subjects With IDDMNational Center For Research Resources
    1998 - 1999
  • PET Detection Of The Diabetic Heart
    PET Detection Of The Diabetic HeartNational Center For Research Resources
    1998 - 1999
  • Evaluate Safety, Efficacy And Tolerability Of 3 Fixed Doses Of SDZ Djn 608
    Evaluate Safety, Efficacy And Tolerability Of 3 Fixed Doses Of SDZ Djn 608National Center For Research Resources
    1998 - 1999
  • Intra And Intersubject Variability In Absorption Of Subcutaneous Insulin
    Intra And Intersubject Variability In Absorption Of Subcutaneous InsulinNational Center For Research Resources
    1998 - 1999
  • Human Insulin Analogue X14 &Regular Human Insulin As Meal Related Insulin
    Human Insulin Analogue X14 &Regular Human Insulin As Meal Related InsulinNational Center For Research Resources
    1998 - 1999
  • Evaluation Of Dose Ranges Of SC 6610 In Treatment Of Hypertension
    Evaluation Of Dose Ranges Of SC 6610 In Treatment Of HypertensionNational Center For Research Resources
    1998 - 1999
  • Sucralose Versus Placebo On Glucose Homeostasis In NIDDM Subjects
    Sucralose Versus Placebo On Glucose Homeostasis In NIDDM SubjectsNational Center For Research Resources
    1997 - 1999
  • Oral Ana756 In Treatment Of Patients With Essential Hypertension
    Oral Ana756 In Treatment Of Patients With Essential HypertensionNational Center For Research Resources
    1997 - 1999
  • Renal Protective Effects Of Losartan In Patients With NIDDM And Nephropathy
    Renal Protective Effects Of Losartan In Patients With NIDDM And NephropathyNational Center For Research Resources
    1997 - 2002
  • Telmisartan As Monotherapy Or In Combination With Other Antihypertensive Drugs
    Telmisartan As Monotherapy Or In Combination With Other Antihypertensive DrugsNational Center For Research Resources
    1997 - 1999
  • Venlafaxine ER Capsules For Chronic Pain Associated With Diabetic Neuropathy
    Venlafaxine ER Capsules For Chronic Pain Associated With Diabetic NeuropathyNational Center For Research Resources
    1997 - 1999
  • OPEN Label Long Term Tolerability Of Pioglitazone AD 48333 In NIDDM Patients
    OPEN Label Long Term Tolerability Of Pioglitazone AD 48333 In NIDDM PatientsNational Center For Research Resources
    1997 - 2002
  • Tolerability Of Pramlintide In Patients With Type I Diabetes
    Tolerability Of Pramlintide In Patients With Type I DiabetesNational Center For Research Resources
    1997 - 1999
  • Oral Zopolrestat In Subjects With Peripheral Symmetical Diabetic Polyneuropathy
    Oral Zopolrestat In Subjects With Peripheral Symmetical Diabetic PolyneuropathyNational Center For Research Resources
    1997 - 1997
  • Two Formulations Of HOE 901 Insulin In Comparison To NPH Insulin In NIDDM
    Two Formulations Of HOE 901 Insulin In Comparison To NPH Insulin In NIDDMNational Center For Research Resources
    1997 - 1997
  • Telmisartan And Hctz In Patients With Mild To Moderate Essential Hypertension
    Telmisartan And Hctz In Patients With Mild To Moderate Essential HypertensionNational Center For Research Resources
    1997 - 1997
  • Miglitol As Compared To A Fixed Dose Of Sulfonylurea In The Treatment Of NIDDM
    Miglitol As Compared To A Fixed Dose Of Sulfonylurea In The Treatment Of NIDDMNational Center For Research Resources
    1996 - 1997
  • Diabetes Registry--Research And Education Facility
    Diabetes Registry--Research And Education FacilityNational Center For Research Resources
    1996 - 2002
  • Aminoguanidine In Diabetic Patients With Overt Diabetic Nephropathy
    Aminoguanidine In Diabetic Patients With Overt Diabetic NephropathyNational Center For Research Resources
    1996 - 1999
  • Orlistat In The Treatment Of Obese Subjects With NIDDM
    Orlistat In The Treatment Of Obese Subjects With NIDDMNational Center For Research Resources
    1996 - 1997
  • Oral Zololrestat In Normotensive, Type I Diabetics With Incipient Nephropathy
    Oral Zololrestat In Normotensive, Type I Diabetics With Incipient NephropathyNational Center For Research Resources
    1996 - 2002
  • Efect Of Ac137 On Plasma Glucose Profiles In Patients With Type II Diabetes
    Efect Of Ac137 On Plasma Glucose Profiles In Patients With Type II DiabetesNational Center For Research Resources
    1996 - 1999
  • Metformin Hydrochloride In Patients With Noninsulin Dependent Diabetes Mellitus
    Metformin Hydrochloride In Patients With Noninsulin Dependent Diabetes MellitusNational Center For Research Resources
    1996 - 1997
  • Pimagedine In Patients With Type II Diabetes Mellitus And Diabetic Nephropathy
    Pimagedine In Patients With Type II Diabetes Mellitus And Diabetic NephropathyNational Center For Research Resources
    1996 - 1999
  • Oral Dose Levels Of Rs-15385-197 In Men With Erectile Disorder
    Oral Dose Levels Of Rs-15385-197 In Men With Erectile DisorderNational Center For Research Resources
    1996 - 1996
  • Angiotensin Converting Enzyme Inhibition In Diabetic Nephropathy
    Angiotensin Converting Enzyme Inhibition In Diabetic NephropathyNational Center For Research Resources
    1996 - 1997
  • U-98079a (DAV6215CL) Capsules In The Treatment Of Mixed Anxiety And Depression
    U-98079a (DAV6215CL) Capsules In The Treatment Of Mixed Anxiety And DepressionNational Center For Research Resources
    1996 - 1996
  • Triproamylin On Glucose Profile And Pharmacokinetics In Juvenile Onset Diabetes
    Triproamylin On Glucose Profile And Pharmacokinetics In Juvenile Onset DiabetesNational Center For Research Resources
    1996 - 1996
  • Ci-991 In NIDDM To Assess Potential Effects On Cardiac Mass And Function
    Ci-991 In NIDDM To Assess Potential Effects On Cardiac Mass And FunctionNational Center For Research Resources
    1996 - 1997
  • Occlusions Of Insulin Delivery In Continuous Subcutaneous Insulin Infusion (Human
    Occlusions Of Insulin Delivery In Continuous Subcutaneous Insulin Infusion (HumanNational Center For Research Resources
    1990 - 1990
  • Multicenter Clinical Trial Converting Enzyme Inhibition In Diabetic Nephropathy
    Multicenter Clinical Trial Converting Enzyme Inhibition In Diabetic NephropathyNational Center For Research Resources
    1990 - 1990
  • Energy Metabolism During Anesthesia
    Energy Metabolism During AnesthesiaNational Center For Research Resources
    1990 - 1990
  • Effect Of Captopril On Microalbuminia/Insulin Dependent Diabetes Mellitus
    Effect Of Captopril On Microalbuminia/Insulin Dependent Diabetes MellitusNational Center For Research Resources
    1990 - 1990

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • Anthem Blue Access Choice PPO
  • Anthem Blue Access PPO
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Coventry Health Care PPO Platinum
  • Coventry Missouri - HMO/POS
  • First Choice
  • First Health PPO
  • Great West PPO
  • HealthLink PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Alternate Names

  • Dr. Janet McGill, Dr. Janet McGill, MD, Dr. J McGill, Dr. Janet B McGill

17 Colleague Invites!
Is this you? If so, register to see 17 messages.

Physicians, view Dr. McGill's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV